02 Mar 2018
Medlab Clinical on track for analytical release of Nanabis pain management medicine
Medlab Clinical Ltd (ASX:MDC), a developer of cannabis based medicines, has made solid progress with its proprietary pain management product, Nanabis.
Medlab Clinical on track for analytical release of Nanabis pain management medicine
CHEWING GUM COMPOSITION CANNABINOIDS & OPIOID AGONISTS / ANTAGANISTS
26 Jun 2019
READ FULL ARTICLE HERE
Read More
NASAL CANNABIDIOL COMPOSITIONS - INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT
26 Jun 2019
Related Applications [0001] This application...
Read More
Medlab Clinical on track for analytical release of Nanabis pain management medicine
26 Jun 2019
02 Mar 2018Medlab Clinical on track for...
Read More
Geocann Launches Cannabidiol (CBD) Soft Gel Formulations Utilizing Patented Drug Delivery Technology
26 Jun 2019
Condition-specific portfolio showcases...
Read More
Afriplex Gears Up For SA’s Cannabis Explosion
17 Apr 2019
Afriplex, the Paarl-based botanicals ingredient...
Read More
ASTM International and ICCI Sign MOU on Cannabis Standards
12 Dec 2018
ASTM International and the International...
Read MorePO Box 2651, Paarl, 7620